Free Trial

CME Group (NASDAQ:CME) Stock Unloaded Rep. Julie Johnson

CME Group logo with Finance background

Key Points

  • Representative Julie Johnson sold shares of CME Group valued between $1,001 and $15,000 on August 14th, as disclosed in a recent filing.
  • CME Group's recent quarterly earnings report revealed an EPS of $2.96, which exceeded analysts' expectations, alongside a 10.4% increase in revenue year-over-year.
  • The company announced a quarterly dividend of $1.25, with a dividend yield of 1.9%, to be paid to shareholders on September 25th.
  • MarketBeat previews the top five stocks to own by October 1st.

Representative Julie Johnson (D-Texas) recently sold shares of CME Group Inc. NASDAQ: CME. In a filing disclosed on September 11th, the Representative disclosed that they had sold between $1,001 and $15,000 in CME Group stock on August 14th. The trade occurred in the Representative's "CHASE BROKERAGE ACCOUNT (3935)" account.

Representative Julie Johnson also recently made the following trade(s):

  • Sold $1,001 - $15,000 in shares of McDonald's NYSE: MCD on 8/14/2025.
  • Sold $1,001 - $15,000 in shares of Eli Lilly and Company NYSE: LLY on 8/14/2025.
  • Sold $1,001 - $15,000 in shares of Arthur J. Gallagher & Co. NYSE: AJG on 8/14/2025.
  • Sold $1,001 - $15,000 in shares of Parker-Hannifin NYSE: PH on 8/14/2025.
  • Sold $1,001 - $15,000 in shares of Charles Schwab NYSE: SCHW on 8/14/2025.
  • Sold $1,001 - $15,000 in shares of Fidelity National Information Services NYSE: FIS on 8/14/2025.
  • Sold $1,001 - $15,000 in shares of ConocoPhillips NYSE: COP on 8/14/2025.
  • Sold $1,001 - $15,000 in shares of Home Depot NYSE: HD on 8/14/2025.
  • Sold $1,001 - $15,000 in shares of Dover NYSE: DOV on 8/14/2025.
  • Sold $1,001 - $15,000 in shares of UnitedHealth Group NYSE: UNH on 8/14/2025.

CME Group Stock Performance

Shares of NASDAQ:CME traded down $0.08 during trading on Friday, reaching $262.30. The company had a trading volume of 1,537,684 shares, compared to its average volume of 1,837,493. CME Group Inc. has a fifty-two week low of $212.38 and a fifty-two week high of $290.79. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The stock's fifty day moving average price is $273.60 and its 200 day moving average price is $270.45. The firm has a market capitalization of $94.53 billion, a price-to-earnings ratio of 25.39, a price-to-earnings-growth ratio of 4.75 and a beta of 0.43.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping the consensus estimate of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The business had revenue of $1.69 billion during the quarter, compared to analysts' expectations of $1.68 billion. During the same quarter in the prior year, the business earned $2.56 earnings per share. The company's quarterly revenue was up 10.4% compared to the same quarter last year. As a group, equities research analysts predict that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be paid a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date is Tuesday, September 9th. CME Group's dividend payout ratio (DPR) is 48.40%.

Insider Activity at CME Group

In other CME Group news, Director William R. Shepard acquired 256 shares of the company's stock in a transaction on Wednesday, June 25th. The shares were bought at an average cost of $270.53 per share, for a total transaction of $69,255.68. Following the acquisition, the director directly owned 258,196 shares of the company's stock, valued at $69,849,763.88. This trade represents a 0.10% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Sunil Cutinho sold 11,896 shares of CME Group stock in a transaction that occurred on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the sale, the insider owned 17,440 shares in the company, valued at $4,734,436.80. This represents a 40.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.30% of the company's stock.

Hedge Funds Weigh In On CME Group

Hedge funds and other institutional investors have recently modified their holdings of the company. Heartland Bank & Trust Co acquired a new position in CME Group during the 1st quarter worth approximately $377,000. Catalyst Capital Advisors LLC lifted its position in CME Group by 256.9% during the 1st quarter. Catalyst Capital Advisors LLC now owns 3,662 shares of the financial services provider's stock worth $971,000 after acquiring an additional 2,636 shares in the last quarter. OMNI 360 Wealth Inc. acquired a new position in CME Group during the 1st quarter worth approximately $367,000. Fulcrum Equity Management acquired a new position in CME Group during the 1st quarter worth approximately $258,000. Finally, AIA Group Ltd lifted its position in CME Group by 17.8% during the 1st quarter. AIA Group Ltd now owns 16,645 shares of the financial services provider's stock worth $4,416,000 after acquiring an additional 2,510 shares in the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts have recently commented on CME shares. Barclays set a $298.00 price target on CME Group and gave the stock an "equal weight" rating in a research note on Thursday, July 24th. UBS Group cut their price objective on CME Group from $305.00 to $285.00 and set a "neutral" rating for the company in a research report on Monday, September 8th. Wall Street Zen cut CME Group from a "hold" rating to a "sell" rating in a research report on Sunday, July 13th. Piper Sandler raised their price target on CME Group from $283.00 to $296.00 and gave the company an "overweight" rating in a research report on Tuesday, July 15th. Finally, Erste Group Bank cut CME Group from a "strong-buy" rating to a "hold" rating in a research report on Saturday, May 24th. Four research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $260.60.

Check Out Our Latest Research Report on CME

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas' 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027. Johnson (Democratic Party) ran for election to the U.S. House to represent Texas' 32nd Congressional District. She won in the general election on November 5, 2024. Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson's career experience includes working as an attorney.

About CME Group

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.